Securities code: 300273 securities abbreviation: Zhuhai Hokai Medical Instruments Co.Ltd(300273) No.: 2022-011
Zhuhai Hokai Medical Instruments Co.Ltd(300273)
About cooperation with China Huarong Asset Management Co., Ltd. Guangdong Branch
Announcement on signing supplementary agreement II of repayment agreement
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Overview
Zhuhai Hokai Medical Instruments Co.Ltd(300273) (hereinafter referred to as “the company”) convened the 36th meeting of the Fifth Board of directors on January 12, 2022, and deliberated and adopted the proposal on signing supplementary agreement II of repayment agreement with Guangdong Branch of China Huarong Asset Management Co., Ltd. and providing guarantee for Hengyuan leasing with 9 affirmative votes, 0 negative votes and 0 abstention votes.
On December 9, 2019, the company held the fifth meeting of the Fifth Board of directors and the fourth meeting of the Fifth Board of supervisors respectively, deliberated and adopted the proposal on the transfer of the creditor’s rights of Hejia shares held by the holding subsidiary Zhuhai Hengyuan Financial Leasing Co., Ltd. to Guangdong Branch of China Huarong Asset Management Co., Ltd.
In order to optimize the debt maturity structure, the company and Guangdong Branch of China Huarong Asset Management Co., Ltd. (hereinafter referred to as “Huarong company”) have signed supplementary agreement II to optimize and adjust the above debt repayment plan, The holding subsidiaries Zhuhai Hengyuan Financial Leasing Co., Ltd. (hereinafter referred to as “Hengyuan leasing”) and Hao Zhenxi and CAI mengke provide joint and several liability guarantee for the transfer of creditor’s rights. The specific guarantee matters shall be subject to the signed guarantee contract.
According to the provisions of relevant documents such as the Listing Rules of Shenzhen Stock Exchange gem and the guidelines for the standardized operation of companies listed on Shenzhen Stock Exchange gem, the above guarantee measures provided by Hengyuan leasing have been decided by the shareholders of Hengyuan leasing and need to be submitted to the general meeting of shareholders of the company for deliberation.
2、 Related parties to supplementary agreement II of repayment agreement
1. Party A (creditor): Guangdong Branch of China Huarong Asset Management Co., Ltd
Unified social credit Code: 91440101721953418g
Person in charge: Chen Feng
Type: branches of other joint stock limited companies (listed)
Date of establishment: April 29, 2000
Business place: Room 401, floor 8-12, No. 3, Qingyi street, Tianhe District, Guangzhou (for office use only). Business scope: carry out business activities under the authorization of the head office within the business scope approved by Bank Of China Limited(601988) industry supervision and Administration Commission (this project is only selected by branches).
Relationship with the company: no relationship.
2. Party B (debtor): Zhuhai Hokai Medical Instruments Co.Ltd(300273)
3、 Main contents of supplementary agreement II to repayment agreement
1. Party A and Party B signed the creditor’s right transfer agreement (hereinafter referred to as “creditor’s right transfer agreement”) numbered [Guangdong y19190060-9] in November 2019 and the supplementary agreement to the repayment agreement numbered [Guangdong y19190060-11] in January 2020 The supplementary agreement to the repayment agreement (No. [Guangdong y19190060-17]) was signed in March 2020 (hereinafter referred to as “repayment agreement” or “original agreement”).
2. As of December 11, 2021, the remaining debt balance of Party B under the original agreement is RMB 398396451.70, and the remaining restructured debt balance of Party B under the original agreement is RMB 374400000.00. Upon Party B’s application, Party A agrees to give Party B a 12-month grace period for repayment. 3. This extension is the extension of the term of the original agreement and the adjustment of the repayment arrangement. It is the continuation of the original creditor’s right and debt relationship, and does not produce a new creditor’s right and debt relationship.
4. The extension period is 12 months, i.e. from December 11, 2021 to December 10, 2022. During the extension period, the remaining restructuring debt repayment arrangements agreed in article 1.2 are adjusted as follows:
Before March 10, 2022 (inclusive), Party B shall repay the restructuring debt to Party A in total not less than RMB 37440000.00.
Party B shall repay all remaining restructuring debts to Party A before December 10, 2022 (inclusive), i.e. RMB 374400000.00.
5. If Party B fails to repay any restructuring debt in accordance with paragraph 1.3 of this agreement, from the next day of the maturity date, Party A has the right to charge an additional 4% / year on the basis of the restructuring grace compensation rate agreed in paragraph 2.1 of this agreement, that is, the restructuring grace compensation rate will be increased to 15% / year.
6. Grace compensation for debt extension: Party B confirms that it will pay the grace compensation for debt extension to Party A due to the occupation of Party A’s funds. The grace compensation rate during the extension period is 11% / year (including the value-added tax payable by Party A in accordance with the national tax law), which is calculated and collected according to the amount of funds actually occupied by Party B (i.e. restructured debt) and days based on 360 days per year. Restructuring grace compensation is paid quarterly.
7. If Party B fails to repay any period of restructuring grace compensation as agreed in this agreement, from the next day of the maturity date, Party A has the right to charge an additional 4% / year on the basis of the restructuring grace compensation rate agreed in paragraph 2.1 of this agreement, that is, the restructuring grace compensation rate will be increased to 15% / year.
4、 Impact of signing supplementary agreement II of repayment agreement on the company
The company plans to sign supplementary agreement II to the repayment agreement with Huarong company, which is conducive to optimizing the debt maturity structure of the company, improving the capital liquidity of the company, meeting the needs of the company’s operation and development, and will not damage the interests of the company and all shareholders.
5、 Documents for future reference
1. The 36th meeting of the 5th board of directors;
2. Resolution of the 28th meeting of the 5th board of supervisors;
3. Independent opinions of independent directors on Zhuhai Hokai Medical Instruments Co.Ltd(300273) related matters.
It is hereby announced.
Zhuhai Hokai Medical Instruments Co.Ltd(300273) board of directors January 14, 2022
